Intracranial mesenchymal tumor, FET::CREB fusion-positive in the lateral ventricle
Open Access
- 1 January 2023
- journal article
- editorial
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 5 (1) , vdad026
Abstract
Intracranial mesenchymal tumor, FET::CREB fusion-positive, is a recently recognized provisional entity in the 2021 WHO Classification of Tumors of the Central Nervous System.1 These are mesenchymal, nonmeningothelial tumors, with a wide morphologic spectrum.2–4 Mitotic activity is usually low (2). Architectural patterns vary from syncytial or sheet-like to reticular cord-like structures. The stroma can be collagenous or myxoid. A fusion between a FET RNA-binding protein family gene (EWSR1 and FUS) and a member of the CREB family of transcription factors (ATF1, CREB, and CREM) is diagnostic.1 Specifically, EWSR1::CREB fusions have been shown in angiomatoid fibrous histiocytoma and clear cell sarcoma.5,6 Prior nosological designations “intracranial myxoid variant of angiomatoid fibrous histiocytoma,” “intracranial myxoid mesenchymal tumor with EWSR1::CREB family gene fusions” are no longer recommended for this entity.7,8 We report a case of intracranial mesenchymal tumor, FET::CREB fusion-positive, in lateral ventricle of an adult patient.Keywords
Funding Information
- National Cancer Institute
- National Institutes of Health (K08CA241651)
This publication has 15 references indexed in Scilit:
- Sclerosing Epithelioid Fibrosarcoma of the Bone With Rare EWSR1-CREB3L3 Translocation Driving Upregulation of the PI3K/mTOR Signaling PathwayPediatric and Developmental Pathology, 2019
- Expanding the spectrum of translocations in sclerosing epitheloid fibrosarcoma: A new case with EWSR1‐CREB3L3 fusionGenes, Chromosomes and Cancer, 2018
- Natural history of intraventricular meningiomas: systematic reviewNeurosurgical Review, 2018
- A novel EWS‐CREB3L3 gene fusion in a mesenteric sclerosing epithelioid fibrosarcomaGenes, Chromosomes and Cancer, 2017
- Intracranial myxoid mesenchymal tumors with EWSR1–CREB family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity?Brain Pathology, 2017
- EWSR1 Fusions With CREB Family Transcription Factors Define a Novel Myxoid Mesenchymal Tumor With Predilection for Intracranial LocationAmerican Journal of Surgical Pathology, 2017
- Intraventricular TumorsWorld Neurosurgery, 2013
- From the Radiologic Pathology Archives: Intraventricular Neoplasms: Radiologic-Pathologic CorrelationRadioGraphics, 2013
- Factors influencing the risk of local recurrence after resection of a single brain metastasisJournal of Neurosurgery, 2010
- EWSR1‐CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytomaGenes, Chromosomes and Cancer, 2007